Inventor · disambiguated record
Kathleen M. Lee
Also filed as: LEE KATHLEEN · LEE KATHLEEN M
15 granted patents·7 pending applications·87 citations·filing 2005–2017
93Inventor score
Files withHELSINN HEALTHCARE SA16LEE KATHLEEN M2CALDERARI GIORGIO1GIANNOUSIS PETER1INTEKRIN THERAPEUTICS INC1
Top patents by PatentIndex Score
22 records- 0192US8598219B2Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2013·Granted Dec 3, 2013·6 cites·8 claims
- 0292US7960424B2Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2006·Granted Jun 14, 2011·16 cites·6 claims
- 0392US7947725B2Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2006·Granted May 24, 2011·15 cites·2 claims
- 0492US7947724B2Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2005·Granted May 24, 2011·16 cites·14 claims
- 0591US8729094B2Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2013·Granted May 20, 2014·5 cites·30 claims
- 0688US9125905B2Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2015·Granted Sep 8, 2015·2 cites·9 claims
- 0787US8598218B2Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2013·Granted Dec 3, 2013·6 cites·11 claims
- 0887US8518981B2Liquid pharmaceutical formulations of palonosetronCALDERARI GIORGIO·Filed 2011·Granted Aug 27, 2013·11 cites·12 claims
- 0986US9173942B2Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2013·Granted Nov 3, 2015·2 cites·19 claims
- 1083US9066980B2Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2013·Granted Jun 30, 2015·3 cites·16 claims
- 1175US9308266B2Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2013·Granted Apr 12, 2016·1 cites·1 claims
- 1271US9675603B2Solid pharmaceutical compositions of ppary modulatorLEE KATHLEEN M·Filed 2011·Granted Jun 13, 2017·4 cites·16 claims
- 1370US2018193262A1Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2017·Application pending·0 cites
- 1469US9457021B1Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2016·Granted Oct 4, 2016·0 cites·20 claims
- 1568US2017042807A1Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2016·Application pending·0 cites
- 1667US9439854B2Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2015·Granted Sep 13, 2016·0 cites·8 claims
- 1764US2014039000A1Liquid pharmaceutical formulations of palonosetronMACCIOCCHI SIMONE·Filed 2013·Application pending·0 cites
- 1862US9457020B2Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2015·Granted Oct 4, 2016·0 cites·3 claims
- 1962US2016317440A1Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2016·Application pending·0 cites
- 2047US2010087481A1Oral pharmaceutical formulations for antidiabetic compoundsLEE KATHLEEN M·Filed 2009·Application pending·0 cites
- 2143US2017273969A1Antidiabetic Solid Pharmaceutical CompositionsINTEKRIN THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2243US2007032506A1Crystalline forms of (2r-trans)-6-chloro-5[[4-[(4-fluorophenyl)methyl]-2,5-dimethyl-1-piperazinyl]carbonyl]-n,n, 1-trimethyl-alpha-oxo-1h-indole-3-acetamide monohydrochlorideGIANNOUSIS PETER·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →